Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/CE

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EV/CE History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/CE(x) 3.982.981.180.961.18

What is the latest EV/CE ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/CE ratio of GLENMARK PHARMACEUTICALS is 3.98 based on Mar2025 Consolidated results.
Year EV/CE
Mar20253.98
Mar20242.98
Mar20231.18
Mar20220.96
Mar20211.18

How is EV/CE of GLENMARK PHARMACEUTICALS Trending?

Years EV/CE % Change
Mar2025 3.98
33.56
Mar2024 2.98
152.54
Mar2023 1.18
22.92
Mar2022 0.96
-18.64
Mar2021 1.18 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/CE ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,916.1 Cr 3.8% -1.5% 44.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.8%

-1.5%

44.3%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses